{"entity":{"type":"insider","cik":"0001355758","url":"/insider/0001355758","json_url":"/insider/0001355758.json","name":"Castelein Caley","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2017-03-17","last":"2023-10-27","span_basis":"filed_date"},"name_variants":[{"name":"Castelein Caley","source":"filing","n_filings":5,"first_seen":"2017-03-17","last_seen":"2023-10-27"}],"transactions":[{"id":8681237,"accession":"0001209191-23-053791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053791","line_url":"/filing/0001209191-23-053791#line-2","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"Tourmaline Bio, Inc.","issuer_ticker":"TRML","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15800.0,"shares_display":"15,800","price_per_share":14.55,"price_display":"14.55","price_state":"stated","total_value":229890.0,"total_display":"229,890.00","shares_owned_after":516519.0,"shares_owned_after_display":"516,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-27","filed_date":"2023-10-27","scope":"insider"},{"id":8681234,"accession":"0001209191-23-053791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053791","line_url":"/filing/0001209191-23-053791#line-1","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"Tourmaline Bio, Inc.","issuer_ticker":"TRML","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4200.0,"shares_display":"4,200","price_per_share":12.07,"price_display":"12.07","price_state":"stated","total_value":50694.0,"total_display":"50,694.00","shares_owned_after":500719.0,"shares_owned_after_display":"500,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-25","filed_date":"2023-10-27","scope":"insider"},{"id":8129597,"accession":"0001628280-23-025331","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-23-025331","line_url":"/filing/0001628280-23-025331#line-3","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1545600.0,"shares_display":"1,545,600","price_per_share":0.071,"price_display":"0.07","price_state":"stated","total_value":109737.6,"total_display":"109,737.60","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":8129596,"accession":"0001628280-23-025331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-025331","line_url":"/filing/0001628280-23-025331#line-2","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":641033.0,"shares_display":"641,033","price_per_share":0.07,"price_display":"0.07","price_state":"stated","total_value":44872.31,"total_display":"44,872.31","shares_owned_after":99047.0,"shares_owned_after_display":"99,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":8129595,"accession":"0001628280-23-025331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-025331","line_url":"/filing/0001628280-23-025331#line-1","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158397.0,"shares_display":"158,397","price_per_share":0.068,"price_display":"0.07","price_state":"stated","total_value":10770.996,"total_display":"10,771.00","shares_owned_after":740080.0,"shares_owned_after_display":"740,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":6830530,"accession":"0001628280-22-014015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-22-014015","line_url":"/filing/0001628280-22-014015#line-2","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1065000.0,"shares_display":"1,065,000","price_per_share":2.5366,"price_display":"2.54","price_state":"stated","total_value":2701479.0,"total_display":"2,701,479.00","shares_owned_after":1545600.0,"shares_owned_after_display":"1,545,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-12","scope":"insider"},{"id":6830525,"accession":"0001628280-22-014015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-014015","line_url":"/filing/0001628280-22-014015#line-1","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":2.5704,"price_display":"2.57","price_state":"stated","total_value":899640.0,"total_display":"899,640.00","shares_owned_after":480600.0,"shares_owned_after_display":"480,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider"},{"id":4604855,"accession":"0000899243-21-034553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-034553","line_url":"/filing/0000899243-21-034553#line-1","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"Aadi Bioscience, Inc.","issuer_ticker":"AADI","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":259998.0,"shares_display":"259,998","price_per_share":13.077,"price_display":"13.08","price_state":"stated","total_value":3399993.846,"total_display":"3,399,993.85","shares_owned_after":259998.0,"shares_owned_after_display":"259,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-30","scope":"insider"},{"id":4604558,"accession":"0000899243-17-008162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-008162","line_url":"/filing/0000899243-17-008162#line-1","is_derivative":false,"issuer_cik":"0001355758","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001355758","owner_cik":"0001355758","owner_name":"Castelein Caley","owner_url":"/insider/0001355758","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","shares_owned_after":1611408.0,"shares_owned_after_display":"1,611,408","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001827506","name":"Tourmaline Bio, Inc.","url":"/issuer/0001827506","role":"Director","n_filings":1,"first_seen":"2023-10-27","last_seen":"2023-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001597313","name":"ViewRay, Inc.","url":"/issuer/0001597313","role":"Director","n_filings":2,"first_seen":"2022-05-12","last_seen":"2023-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001422142","name":"Aadi Bioscience, Inc.","url":"/issuer/0001422142","role":"Director","n_filings":2,"first_seen":"2017-03-17","last_seen":"2021-08-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001355758","retrieved_at":"2026-08-21T13:14:40+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}